tiprankstipranks
Rafarma Pharmaceuticals Inc (RAFA)
OTHER OTC:RAFA
US Market
RAFA
Rafarma Pharmaceuticals
RESEARCH TOOLSreports

Rafarma Pharmaceuticals (RAFA) Ratios

14 Followers

Rafarma Pharmaceuticals Ratios

RAFA's free cash flow for Q4 2024 was $0.43. For the 2024 fiscal year, RAFA's free cash flow was decreased by $ and operating cash flow was $0.33. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.13 1.13 1.13 1.23 3.03
Quick Ratio
 1.03 1.03 1.03 1.18 1.93
Cash Ratio
 0.05 0.04 0.05 0.04 1.01
Solvency Ratio
 0.13 0.23 0.16 0.27 0.25
Operating Cash Flow Ratio
 0.04 0.08 0.03 -30.64 1.06
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 52.14
Net Current Asset Value
$ 207.00K$ 172.00K$ 207.00K$ 385.00K$ 33.54M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 <0.01 0.00 0.00 <0.01
Debt-to-Equity Ratio
 0.00 <0.01 0.00 0.00 0.01
Debt-to-Capital Ratio
 0.00 <0.01 0.00 0.00 0.01
Long-Term Debt-to-Capital Ratio
 0.00 <0.01 0.00 0.00 <0.01
Financial Leverage Ratio
 1.16 1.14 1.16 1.16 1.26
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 14.42
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 <0.01 0.00 0.00 0.02
Interest Debt Per Share
 0.00 <0.01 0.00 0.00 0.01
Net Debt to EBITDA
 -0.25 -0.07 -0.23 -0.13 -2.66
Profitability Margins
Gross Profit Margin
6.37%8.29%7.42%5.92%35.47%
EBIT Margin
3.55%5.33%3.77%3.54%9.68%
EBITDA Margin
3.55%5.33%3.77%5.20%10.04%
Operating Profit Margin
4.07%5.33%4.46%3.09%11.12%
Pretax Profit Margin
3.57%4.65%3.78%3.55%9.68%
Net Profit Margin
2.50%3.80%2.93%2.69%7.71%
Continuous Operations Profit Margin
2.50%3.80%2.93%2.69%7.71%
Net Income Per EBT
69.94%81.73%77.55%75.83%79.69%
EBT Per EBIT
87.78%87.32%84.69%115.02%87.06%
Return on Assets (ROA)
1.84%2.91%2.21%2.24%5.05%
Return on Equity (ROE)
2.13%3.32%2.56%2.60%6.37%
Return on Capital Employed (ROCE)
3.47%4.65%3.90%2.98%8.88%
Return on Invested Capital (ROIC)
2.43%3.80%3.03%2.26%7.04%
Return on Tangible Assets
1.84%2.91%2.21%2.24%5.05%
Earnings Yield
4.20%14.50%3.70%1.19%12.88%
Efficiency Ratios
Receivables Turnover
 5.46 6.35 5.60 5.39 4.16
Payables Turnover
 5.28 6.06 5.36 6.08 2.42
Inventory Turnover
 53.08 53.27 53.87 102.53 2.11
Fixed Asset Turnover
 77.57 79.80 79.63 88.13 1.60
Asset Turnover
 0.74 0.77 0.75 0.83 0.65
Working Capital Turnover Ratio
 42.72 45.66 30.67 0.55 1.78
Cash Conversion Cycle
 4.66 4.17 3.85 11.24 109.78
Days of Sales Outstanding
 66.91 57.51 65.18 67.71 87.70
Days of Inventory Outstanding
 6.88 6.85 6.78 3.56 173.17
Days of Payables Outstanding
 69.12 60.20 68.10 60.02 151.09
Operating Cycle
 73.78 64.36 71.95 71.27 260.87
Cash Flow Ratios
Operating Cash Flow Per Share
 <0.01 <0.01 <0.01 -0.58 0.21
Free Cash Flow Per Share
 >-0.01 >-0.01 0.00 0.00 0.08
CapEx Per Share
 <0.01 <0.01 <0.01 0.58 0.14
Free Cash Flow to Operating Cash Flow
 -0.02 -0.14 0.00 0.00 0.36
Dividend Paid and CapEx Coverage Ratio
 0.99 0.88 1.00 -1.00 1.55
Capital Expenditure Coverage Ratio
 0.99 0.88 1.00 -1.00 1.55
Operating Cash Flow Coverage Ratio
 0.00 4.87 0.00 0.00 20.65
Operating Cash Flow to Sales Ratio
 <0.01 0.01 <0.01 -5.00 0.29
Free Cash Flow Yield
-0.02%-0.66%0.00%0.00%17.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 17.47 6.90 27.06 84.01 7.76
Price-to-Sales (P/S) Ratio
 0.44 0.26 0.79 2.26 0.60
Price-to-Book (P/B) Ratio
 0.37 0.23 0.69 2.18 0.49
Price-to-Free Cash Flow (P/FCF) Ratio
 -3.86K -150.44 0.00 0.00 5.76
Price-to-Operating Cash Flow Ratio
 58.51 21.49 163.57 -0.45 2.05
Price-to-Earnings Growth (PEG) Ratio
 -0.06 0.21 -8.39 -0.89 -0.14
Price-to-Fair Value
 0.37 0.23 0.69 2.18 0.49
Enterprise Value Multiple
 12.05 4.85 20.82 43.40 3.31
Enterprise Value
 5.19M 2.37M 7.12M 22.87M 21.37M
EV to EBITDA
 16.53 4.85 20.82 43.40 3.31
EV to Sales
 0.59 0.26 0.78 2.26 0.33
EV to Free Cash Flow
 -5.19K -148.25 0.00 0.00 3.20
EV to Operating Cash Flow
 78.62 21.18 161.82 -0.45 1.14
Tangible Book Value Per Share
 0.12 0.12 0.12 0.12 0.89
Shareholders’ Equity Per Share
 0.12 0.12 0.12 0.12 0.89
Tax and Other Ratios
Effective Tax Rate
 0.30 0.18 0.22 0.24 0.20
Revenue Per Share
 0.10 0.10 0.10 0.12 0.73
Net Income Per Share
 <0.01 <0.01 <0.01 <0.01 0.06
Tax Burden
 0.70 0.82 0.78 0.76 0.80
Interest Burden
 1.01 0.87 1.00 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.01 0.02 0.02 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.30 0.32 0.17 -185.61 3.78
Currency in USD